213 related articles for article (PubMed ID: 12527887)
1. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways.
Belka C; Gruber C; Jendrossek V; Wesselborg S; Budach W
Oncogene; 2003 Jan; 22(2):176-85. PubMed ID: 12527887
[TBL] [Abstract][Full Text] [Related]
2. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation.
Belka C; Marini P; Lepple-Wienhues A; Budach W; Jekle A; Los M; Lang F; Schulze-Osthoff K; Gulbins E; Bamberg M
Oncogene; 1999 Sep; 18(35):4983-92. PubMed ID: 10490833
[TBL] [Abstract][Full Text] [Related]
4. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
5. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
Belka C; Rudner J; Wesselborg S; Stepczynska A; Marini P; Lepple-Wienhues A; Faltin H; Bamberg M; Budach W; Schulze-Osthoff K
Oncogene; 2000 Feb; 19(9):1181-90. PubMed ID: 10713706
[TBL] [Abstract][Full Text] [Related]
6. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
7. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells.
Kim MJ; Lee KH; Lee SJ
FEBS J; 2008 May; 275(9):2096-108. PubMed ID: 18373696
[TBL] [Abstract][Full Text] [Related]
9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
10. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
Chen CY; Juo P; Liou JS; Li CQ; Yu Q; Blenis J; Faller DV
Cell Growth Differ; 2001 Jun; 12(6):297-306. PubMed ID: 11432804
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.
Sarker M; Ruiz-Ruiz C; Robledo G; López-Rivas A
Oncogene; 2002 Jun; 21(27):4323-7. PubMed ID: 12082620
[TBL] [Abstract][Full Text] [Related]
12. Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line.
Sarker M; Ruiz-Ruiz C; López-Rivas A
Cell Death Differ; 2001 Feb; 8(2):172-81. PubMed ID: 11313719
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine kinase p56lck-deficiency confers hypersusceptibility to rho-fluorophenylalanine (pFPhe)-induced apoptosis by augmenting mitochondrial apoptotic pathway in human Jurkat T cells.
Park HS; Jun DY; Han CR; Kim YH
Biochem Biophys Res Commun; 2008 Dec; 377(1):280-5. PubMed ID: 18845126
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
15. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
Izeradjene K; Douglas L; Delaney AB; Houghton JA
Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.
Belka C; Schmid B; Marini P; Durand E; Rudner J; Faltin H; Bamberg M; Schulze-Osthoff K; Budach W
Oncogene; 2001 Apr; 20(17):2190-6. PubMed ID: 11360204
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
20. Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.
Rudner J; Jendrossek V; Lauber K; Daniel PT; Wesselborg S; Belka C
Oncogene; 2005 Jan; 24(1):130-40. PubMed ID: 15531922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
